Atlas Venture Associates X, LLC's Net Worth

$601 Million

Estimate Recalculated Mar 1, 2024 07:50PM EST

Who is Atlas Venture Associates X, LLC?

Atlas Venture Associates X, LLC has an estimated net worth of $601 Million. This is based on reported shares across multiple companies, which include Day One Biopharmaceuticals Holding Co LLC, Generation Bio Co., Replimune Group, Inc., Ikena Oncology, Inc., Kymera Therapeutics, Inc., Magenta Therapeutics, Inc., Disc Medicine, Inc., and AVROBIO, Inc..

SEC CIK

Atlas Venture Associates X, LLC's CIK is 0001742765

Past Insider Trading and Trends

2018 was Atlas Venture Associates X, LLC's most active year for acquiring shares with 6 total transactions. Atlas Venture Associates X, LLC's most active month to acquire stocks was the month of May. 2021 was Atlas Venture Associates X, LLC's most active year for disposing of shares, totalling 47 transactions. Atlas Venture Associates X, LLC's most active month to dispose stocks was the month of November. 2019 saw Atlas Venture Associates X, LLC paying a total of $15,000,003.50 for 825,056 shares, this is the most they've acquired in one year. In 2021 Atlas Venture Associates X, LLC cashed out on 35,155,530 shares for a total of $45,968,313.25, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Generation Bio Co. (GBIO) Snapshot price: $1.875

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-99.26%
-81.09K
$25.40
-$2,059,519.16
608
Scheduled
Sep 27 - Sep 29
Form 4
-62.30%
-135.00K
$26.02
-$3,511,992.53
81.7K
Scheduled
Sep 22 - Sep 24
Form 4
-98.08%
-31.01K
$25.86
-$801,618.16
608
Scheduled
Jun 24
Form 4
-85.41%
-185.08K
$25.05
-$4,635,967.02
31.62K
Scheduled
Jun 21 - Jun 23
Form 4
-100.00%
-140.68K
$25.92
-$3,646,968.15
0
Scheduled
Apr 12 - Apr 14
Form 4
-47.46%
-127.09K
$28.20
-$3,583,860.22
140.68K
Scheduled
Apr 7 - Apr 9
Form 4
+387.54%
10.04M
12.63M
Jun 16
Form 3
0
0
No matching records found

Replimune Group, Inc. (REPL) Snapshot price: $7.44

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
4.45M
4.45M
Jul 24
Form 3
0
0
No matching records found

Ikena Oncology, Inc. (IKNA) Snapshot price: $1.43

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+2,809.29%
4.75M
4.92M
Mar 30
Form 3
0
0
No matching records found

Kymera Therapeutics, Inc. (KYMR) Snapshot price: $34.3

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-2.11%
-126.47K
$30.22
-$3,821,738.64
5.86M
Scheduled
Jan 11 - Jan 12
Form 4
-6.00%
-382.24K
$31.36
-$11,985,953.69
5.98M
Scheduled
Dec 14 - Dec 15
Form 4
-3.34%
-220.02K
$30.01
-$6,602,952.38
6.37M
Scheduled
Nov 2 - Nov 3
Form 4
-4.20%
-288.70K
$30.26
-$8,735,143.37
6.59M
Scheduled
Oct 28 - Nov 1
Form 4
-100.00%
-242.13K
$61.00
-$14,770,113.00
0
Aug 11
Form 4
-100.00%
-229.35K
$56.50
-$12,958,275.00
0
Mar 12
Form 4
+1,104.37%
8.31M
9.06M
Aug 25
Form 3
0
0
No matching records found

Magenta Therapeutics, Inc. (DNTH) Snapshot price: $23.49

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-15.00%
-726.50K
$17.86
-$254,415.70
4.12M
Mar 20
Form 4
+4,906.38%
4.75M
4.84M
Jun 25
Form 3
0
0
No matching records found